Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system

被引：0
|
作者：
Jiao-Jiao Chen
Xue-Chen Huo
Shao-Xia Wang
Fei Wang
Quan Zhao
机构：
[1] Yantai Yuhuangding Hospital,Department of Pharmacy
[2] Yantai Yuhuangding Hospital,Department of Hepatological Surgery
[3] Yantai University,College of Pharmacy
来源：
International Journal of Clinical Pharmacy | 2022年 / 44卷
关键词：
Adverse drug reactions; Daptomycin; FAERS; Real-world; Signal mining;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1351 / 1360
页数：9
相关论文
共 50 条
  • [1] Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system
    Chen, Jiao-Jiao
    Huo, Xue-Chen
    Wang, Shao-Xia
    Wang, Fei
    Zhao, Quan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1351 - 1360
  • [2] A real-world pharmacovigilance study of tafasitamab: data mining of the US food and drug administration adverse event reporting system
    Xu, Zhongliang
    Feng, Shimei
    Huang, Dan
    Wang, Hongli
    Liu, Jiating
    Shen, Zhengze
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [3] Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
    Liang, Yankun
    Ma, Lin
    Wang, Yuting
    Zheng, Jingping
    Su, Ling
    Lyu, Jun
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [4] Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib
    Liu, Zhijing
    Wu, Dongzhi
    Ke, Chengjie
    Nian, Qichun
    Chen, Yan
    Huang, Yaping
    Chen, Maohua
    ONCOLOGY, 2024, 102 (12) : 1084 - 1096
  • [5] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Wei, Lianhui
    Tian, Ye
    Chen, Xiao
    Guo, Xiaojing
    Chen, Chenxin
    Zheng, Yi
    Xu, Jinfang
    Ye, Xiaofei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (03) : 622 - 629
  • [6] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Lianhui Wei
    Ye Tian
    Xiao Chen
    Xiaojing Guo
    Chenxin Chen
    Yi Zheng
    Jinfang Xu
    Xiaofei Ye
    International Journal of Clinical Pharmacy, 2023, 45 : 622 - 629
  • [7] A real-world disproportionality analysis of the US Food and Drug Administration (FDA) adverse event reporting system (FAERS) events for Durvalumab
    Zou, Ting
    Li, Zhuoyang
    Wang, Tianhong
    Deng, Shuang
    Wang, Siman
    Hua, Yusi
    BMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01):
  • [8] A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system
    Fang, Zhihong
    Xu, Zhiqiang
    Zhu, Wei
    Yu, Mingming
    Ji, Chunmei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Data Mining and Analysis for Iodinated Contrast Media Adverse Event Signals Based on the Food and Drug Administration Adverse Event Reporting System Database
    Tan, Juntao
    Yu, Yue
    He, Yuxin
    Zheng, Jiangyuan
    Tan, Qingzhu
    Zhang, Xiao
    Wan, Chao
    Zhang, Zhengyu
    Wu, Xiaoxin
    Tan, Rui
    CLINICAL THERAPEUTICS, 2025, 47 (01) : 82 - 90
  • [10] Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
    Anna Gaimari
    Michele Fusaroli
    Emanuel Raschi
    Elisa Baldin
    Luca Vignatelli
    Francesco Nonino
    Fabrizio De Ponti
    Jessica Mandrioli
    Elisabetta Poluzzi
    Drug Safety, 2022, 45 : 663 - 673
12345